Inventor · disambiguated record
Jian Qiu
Also filed as: QIU JIAN · QIU JIAN-TAI
50 granted patents·13 pending applications·238 citations·filing 2002–2024
98Inventor score
Files withN30 PHARMACEUTICALS INC14NIVALIS THERAPEUTICS INC12IMMUNESENSOR THERAPEUTICS INC8SUN XICHENG8REPLIDYNE INC4
Top patents by PatentIndex Score
63 records- 0194US8148380B2Antibacterial amide and sulfonamide substituted heterocyclic urea compoundsGUILES JOSEPH·Filed 2008·Granted Apr 3, 2012·46 cites·23 claims
- 0293US11033635B2Antibody-STING agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2020·Granted Jun 15, 2021·3 cites·28 claims
- 0392US11873291B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 16, 2024·3 cites·52 claims
- 0490US8691816B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsWASLEY JAN·Filed 2009·Granted Apr 8, 2014·11 cites·28 claims
- 0590US8470857B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsWASLEY JAN·Filed 2009·Granted Jun 25, 2013·13 cites·7 claims
- 0688US8785643B2Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitorsSUN XICHENG·Filed 2011·Granted Jul 22, 2014·9 cites·22 claims
- 0788US8673961B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsWASLEY JAN·Filed 2009·Granted Mar 18, 2014·7 cites·17 claims
- 0887US8921562B2Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitorsSUN XICHENG·Filed 2011·Granted Dec 30, 2014·8 cites·11 claims
- 0987US8481590B2Chromone inhibitors of S-nitrosoglutathione reductaseSUN XICHENG·Filed 2010·Granted Jul 9, 2013·8 cites·6 claims
- 1086US9221810B2Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Dec 29, 2015·4 cites·15 claims
- 1186US9180119B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2015·Granted Nov 10, 2015·4 cites·19 claims
- 1286US9139528B2Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitorsN30 PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·6 cites·18 claims
- 1386US9012646B2Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitorsN30 PHARMACEUTICALS INC·Filed 2014·Granted Apr 21, 2015·6 cites·23 claims
- 1486US8957105B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2014·Granted Feb 17, 2015·5 cites·19 claims
- 1586US8686015B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2013·Granted Apr 1, 2014·7 cites·8 claims
- 1686US8642628B2Pyrrole inhibitors of S-nitrosoglutathione reductaseWASLEY JAN·Filed 2009·Granted Feb 4, 2014·8 cites·8 claims
- 1785US9138427B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2014·Granted Sep 22, 2015·5 cites·19 claims
- 1884US9364481B2Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Jun 14, 2016·3 cites·22 claims
- 1984US8846736B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsN30 PHARMACEUTICALS INC·Filed 2014·Granted Sep 30, 2014·5 cites·8 claims
- 2084US8669381B2Chromone inhibitors of S-nitrosoglutathione reductaseN30 PHARMACEUTICALS INC·Filed 2013·Granted Mar 11, 2014·5 cites·10 claims
- 2183US9315462B2Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Apr 19, 2016·3 cites·14 claims
- 2282US8741915B2Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitorsSUN XICHENG·Filed 2010·Granted Jun 3, 2014·5 cites·8 claims
- 2382US2025115579A1QUINOLINE cGAS ANTAGONIST COMPOUNDSIMMUNESENSOR THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2480US12134609B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Nov 5, 2024·0 cites·23 claims
- 2580US9433618B2Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2016·Granted Sep 6, 2016·2 cites·9 claims
- 2680US9187447B2S-nitrosoglutathione reductase inhibitorsN30 PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·3 cites·2 claims
- 2780US9029402B2Pyrrole inhibitors of S-nitrosoglutathione reductaseN30 PHARMACEUTICALS INC·Filed 2014·Granted May 12, 2015·4 cites·11 claims
- 2880US8759548B2S-nitrosoglutathione reductase inhibitorsSUN XICHENG·Filed 2011·Granted Jun 24, 2014·4 cites·6 claims
- 2980US7030137B2Substituted thiophenes with antibacterial activityREPLIDYNE INC·Filed 2004·Granted Apr 18, 2006·9 cites·27 claims
- 3079US8946434B2Dihydropyridin-2(1H)-one compound as S-nirtosoglutathione reductase inhibitors and neurokinin-3 receptor antagonistsSUN XICHENG·Filed 2011·Granted Feb 3, 2015·2 cites·10 claims
- 3179US8293919B2Antibacterial sulfone and sulfoxide substituted heterocyclic urea compoundsGUILES JOSEPH·Filed 2008·Granted Oct 23, 2012·4 cites·19 claims
- 3278US9249132B2Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitorsSUN XICHENG·Filed 2011·Granted Feb 2, 2016·2 cites·29 claims
- 3378US7314956B2Multifunctional carrier for the delivery of a pharmacological agent or genetic material into a cellVAXIM INC·Filed 2002·Granted Jan 1, 2008·14 cites·2 claims
- 3476US12091387B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·29 claims
- 3576US9067893B2Dihydropyrimidin-2(1H)-one compounds as S-nitrosoglutathione reductase inhibitorsN30 PHARMACEUTICALS INC·Filed 2014·Granted Jun 30, 2015·2 cites·8 claims
- 3675US12281078B2Quinoline cGAS antagonist compoundsIMMUNESENSOR THERAPEUTICS INC·Filed 2023·Granted Apr 22, 2025·0 cites·26 claims
- 3775US9498466B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsNIVALIS THERAPEUTICS INC·Filed 2015·Granted Nov 22, 2016·1 cites·11 claims
- 3875US8906933B2Dihydropyrimidin-2(1H)-one compounds as neurokinin-3 receptor antagonistsSUN XICHENG·Filed 2010·Granted Dec 9, 2014·3 cites·10 claims
- 3974US9856219B2Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitorsNIVALIS THERAPEUTICS INC·Filed 2016·Granted Jan 2, 2018·1 cites·14 claims
- 4072US12311030B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted May 27, 2025·0 cites·17 claims
- 4172US9674661B2Device-to-device relative localizationCHU DAVID CHIYUAN·Filed 2011·Granted Jun 6, 2017·4 cites·20 claims
- 4271US11213592B2Antibody-sting agonist conjugates and their use in immunotherapyIMMUNESENSOR THERAPEUTICS INC·Filed 2021·Granted Jan 4, 2022·0 cites·26 claims
- 4370US7196119B2Development of new selective estrogen receptor modulatorsUNIV OREGON HEALTH & SCIENCE·Filed 2004·Granted Mar 27, 2007·6 cites·28 claims
- 4465US6809191B2GM-CSF nucleic acid sequencesVAXIM INC·Filed 2002·Granted Oct 26, 2004·3 cites·15 claims
- 4563US9814700B2Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agentsNIVALIS THERAPEUTICS INC·Filed 2016·Granted Nov 14, 2017·0 cites·21 claims
- 4660US2014163092A1Chromone Inhibitors of S-Nitrosoglutathione ReductaseN30 PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4759US2016279117A1Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase InhibitorsNIVALIS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4858US2016108011A1Novel Substituted Bicyclic Aromatic Compounds as S-Nitrosoglutathione Reductase InhibitorsNIVALIS THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 4956US9717706B2Chromone inhibitors of S-nitrosoglutathione reductaseNIVALIS THERAPEUTICS INC·Filed 2015·Granted Aug 1, 2017·0 cites·12 claims
- 5056US2008194842A1Transition Metal Catalyzed Cross-Coupling Of 1-Halo-1-Haloalkene CompoundsREPLIDYNE INC·Filed 2006·Application pending·0 cites
Showing the top 50 of 63 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jian Qiu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →